Linezolid Injection, Solution
Product Images NDC 57664-682

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Linezolid (NDC 57664-682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Case 01

Case 01
This is a description of Linezolid Injection, a drug distributed by Sun Pharmaceutical Industries, Inc. It comes in 10 single-use bags of 300 mL each, with a concentration of 600 mg/300 mL (2 mg/mL). The drug is manufactured by Nang Kuang Pharmaceutical Co., Ltd. in Tainan City, Taiwan. The text contains manufacturing and distribution details, including addresses of the companies involved.*
FDA Label Image

Fig 01

FDA Label Image

Fig 02

Fig 02
This is a graph that shows the concentration of Linezolid, a medication, in plasma at different time intervals (from 2 to 12 hours) after oral administration of 600 mg every 12 hours. The units for concentration are pg/mL.*
FDA Label Image

Fig 03

FDA Label Image

Fig 04

FDA Label Image

Label 01

Label 01
This is a description of a medication called Linezolid Injection, which is administered intravenously. It is a 200mg/100mL solution containing linezolid (2mg/mL), dextrose, sodium citrate, citric acid and water for injection. It is sterile and non-pyrogenic, and should not be used with supplementary medication or in series connections. It is stored at 25°C and checked for leaks before use. The accompanying prescribing information should be consulted. The medication is distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Nang Kuang Pharmaceutical Co., Ltd. in Tainan City, Taiwan.*
FDA Label Image

Label 02

Label 02
This is a description of a medication called Linezolid Injection, administered intravenously. Each mL of the 600 mg/300 mL solution contains linezolid (2 mg), dextrose (50.24mg), sodium citrate (1.64mg), itric acid (0.85mg), and water for injection. The pH is adjusted to 4.8 with sodium hydroxide or hydrochloric acid. The medication is a single-dose container that is sterile and nonpyrogenic. It should not be used with other medications or in series connections. The medication must be stored at 25°C (77°F) with excursions to 15.30°C (59-86°F). It is sensitive to light and must be kept in overwrap until use. Leaks may impair sterility, and the solution may exhibit a yellow color with no adverse effect on potency. The medication is distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Nang Kuang Pharmaceutical Co., Ltd.*
FDA Label Image

Label 03

Label 03
Linezolid Injection is a medication administered via injection with a concentration of 600 mg/300 mL (2 mg/mL). It should be stored between 15-30°C (58-86°F) and protected from light. The medication should not be frozen and the overwrap should be kept prior to use. The package includes the expiration date, lot number, and quantity (10). The National Drug Code is 57664 683 57 and it is distributed by Sun Pharmaceuticals Industries, Inc. from Cranbury, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.